| Prefecture |
Organization |
Institute Director |
Introduction of your Technology, Product and Study |
Technology Classification/Product Classification |
Contact |
| Enterprise |
Beacle, Inc.
|
Yasumasa Goh
|
[Our technology]1. siRNA carrier: The carrier is successfully introduces siRNA to target cells after i.v. injection. Highly efficient siRNA carriers produced by liposomes alone are also available.2. Protein carrier: As a model protein, GFP incorporated BNC can be successfully produced and its ability to introduce the protein into cell has been demonstrated. 3. Antibody-detecting system: The system has been demonstrated to work in Western Blotting, ELISA and immunostains. The Western Blotting prototype version has been developed, and is scheduled to be launched soon.4. Antigen-antibody reaction enhancer (Signal Booster): The reagent for Western Blotting and ELISA are already in market in Japan. A new reagent for immunostaining is under development, and will be available in market soon. |
[Technology Classification]
-A002/Basic Technology/Basic & Fundamental Technology/Protein Synthesis
-BA09/Life Innovation/Drug Discovery & Diagnosis/DDS
[Product Classification]
-A002/Basic Technology/Basic & Fundamental Technology/Reagents
-BA02/Life Innovation/Drug Discovery & Diagnosis/Therapeutic Agent
|
+81-6-6354-7069
|
| Enterprise |
Bio-X Inc.
|
Toshio Tani
|
Micro Bioactivity Analyzer utilizing a High Sensitive Signal Accumulation ISFET Biosensor.This analyzer measures the ionic change in bioactive reaction with high resolution, by directly converting small ionic fluctuations into an electric signal. Unlike previous analyzers, this system does not require a complicated coloring process. It measures simple and short time measurements with micro-level amounts of sample in real-time base. This system enables the direct analysis of total polyphenols in drinks without pre-treatment. |
[Technology Classification]
-A003/Basic Technology/Basic & Fundamental Technology/Analysis of Protein Function
[Product Classification]
-A001/Basic Technology/Basic & Fundamental Technology/Equipments
-A002/Basic Technology/Basic & Fundamental Technology/Reagents
|
+81-75-925-4501
|
| Enterprise |
Carna Biosciences, Inc.
|
Kohichiro Yoshino
|
[Drug Discovery Support Service]We provide drug discovery supporting products and services:1. Kinase Proteins,2. Profiling Services,3. Assay Development,4. Crystallography.[Drug Discovery and Development Business ]We identify and develop new medicines primarily for the treatment of cancer and anti-inflammatory diseases using our own innovative kinase drug discovery platform, QuickScout(TM). |
[Technology Classification]
-A002/Basic Technology/Basic & Fundamental Technology/Protein Synthesis
-A008/Basic Technology/Basic & Fundamental Technology/Bio Informatics
-BA01/Life Innovation/Drug Discovery & Diagnosis/Drugs (Low Molecule)
[Product Classification]
-A002/Basic Technology/Basic & Fundamental Technology/Reagents
-A003/Basic Technology/Basic & Fundamental Technology/Biotechnology Support
|
+81-78-302-7039
|
| Enterprise |
HiPep Laboratories
|
Kiyoshi Nokihara
|
1. Undertaking peptide synthesis and consulting,2. Carbon substrates for biochips,3. Simplified device for synthesizing peptides,4. Reagents for synthesizing peptides,5. Supplies for synthesizing peptides,6. Undertaking analysis for peptides. |
[Product Classification]
-A002/Basic Technology/Basic & Fundamental Technology/Reagents
-A003/Basic Technology/Basic & Fundamental Technology/Biotechnology Support
|
+81-75-813-2101
info@hipep.jp |
| Enterprise |
ISHIHARA SANGYO KAISHA, LTD.
|
Life Science Technology Development Division, R&D Strategy Headquarters
Kenzo Oda
|
We are manufacturing and distributing unique transfection and cell fusion reagents (GenomONE kits) making use of the membrane-fusing potential of HVJ Envelope (inactivated Sendai virus).HVJ-E is a nonproliferative and noninfectious vesicle about 300 nm in diameter on average purified after complete inactivation of Sendai virus genomic RNA. Since the F protein distributed on the surface of HVJ-E has high membrane-fusing activity comparable to that of live virus, it is possible to use HVJ-E itself as a cell-fusing agent or to introduce genes, proteins, anti-cancer agents, etc. in HVJ-E-incorporated form into cells for analysis of their functions. |
[Technology Classification]
-"A001/Basic Technology/Basic &Fundamental Technology/Analysis of Gene Function"
[Product Classification]
-A002/Basic Technology/Basic & Fundamental Technology/Reagents
|
+81-6-6444-1451
http://www.iskweb.co.jp |
| Enterprise |
Kurabo Industries, Ltd.
|
Bio-Medical Dep
Akihiro Inoue
|
We produce and sell automated Nucleic Acid Isolation systems, microscope slide preparation system culture mediums for normal human cells, and anti cancer drug sensitivity testing kits.We are looking for a business partner in pre-clinical testing and In Vitro diagnostic systems. |
[Product Classification]
-A001/Basic Technology/Basic & Fundamental Technology/Equipments
-A002/Basic Technology/Basic & Fundamental Technology/Reagents
|
+81-6-6266-5010
https://www.kurabo.co.jp/bio/contact/contact.php |
| Enterprise |
Nitta Gelatin Inc.
|
Norimichi Soga
|
We develop, produce and sell gelatin and collagen for use in a wide range of applications such as regenerative medicine, tissue engineering, DDS, and cell culture substrate.Our product lineup consists of1) Cellmatrix (collagen for 3D cell culture etc.),2) beMatrix Gelatin (Low endotoxine gelatin),3) Collagen for medical device(Low endotoxine),4) Collagen sponge,5) Collagenase L . |
[Technology Classification]
-BB01/Life Innovation/Regenerative Medicine/ Scaffold & Biomaterial
-A002/Basic Technology/Basic & Fundamental Technology/Protein Synthesis
-A003/Basic Technology/Basic & Fundamental Technology/Analysis of Protein Function
[Product Classification]
-BB04/Life Innovation/Medical Equipment/Medical Supplies
-A002/Basic Technology/Basic & Fundamental Technology/Reagents
|
+81-72-949-5381
info@nitta-gelatin.co.jp |
| Enterprise |
PEPTIDE INSTITUTE, INC
|
Tadashi Teshima (CEO)
|
Our company provides reassuring bioactive peptides and reagents of the highest purity to researchers. In order to contribute to the promotion of basic research, we focus on basic researching for developing and applying new technology while striving to acquire the cutting edge technology of peptide synthesis research. In October 2006, we built a new research institute in Saito (Osaka prefecture, Ibaraki City) with GMP facilities. We have further enhanced our supplying system for basic research reagents and are also committed to supplying bioactive peptides as material for medicine synthesized under GMP conditions and for translational research. |
[Product Classification]
-A002/Basic Technology/Basic & Fundamental Technology/Reagents
|
+81-72-729-4121
info@peptide.co.jp |
| Enterprise |
Protein Crystal Corporation
|
Hajime Mori
|
1) Culture of human naive iPS cells by using of LIF protein beads.2) Medical applications of protein beads.3) A new method for protein beads. |
[Product Classification]
-A002/Basic Technology/Basic & Fundamental Technology/Reagents
|
+81-75-726-2190
hmori@proteincrystal.com |
| Enterprise |
Protosera Inc.
|
Membrane Protein & Ligand Analysis Center
Kenji Tanaka
|
It has been very difficult to determine peptide biomarkers in blood, because most peptides are attached to a number of proteins and lipids during circulation. We produced BLOTCHIP®
mass analysis technology and obtained efficient disease oriented markers for diagnosis of cancers, RA, AMI, and so on. We are now developing versatile apparatus to measure those biomarkers in bed side manners in hospitals. |
[Technology Classification]
-A004/Basic Technology/Basic & Fundamental Technology/Analysis of Protein Structure
-BA11/Life Innovation/Drug Discovery & Diagnosis/Bio-tips
-BA10/Life Innovation/Drug Discovery & Diagnosis/Diagnostic Equipment
[Product Classification]
-A002/Basic Technology/Basic & Fundamental Technology/Reagents
-BA01/Life Innovation/Drug Discovery & Diagnosis/Drugs (Diagnosis)
|
+81-6-6415-9620
info@protosera.co.jp |
| University |
Kansai University, Department of Life Science and Biotechnology, Faculty of Chemistry, Materials and Biotechnology
|
Pharmaceutical Technology
Yasuo Nagaoka (Professor)
|
The lipofection method is a versatile method to deliver genes into mammalian cells. It is widely used in the field of life science including laboratory use to industrial production of biopharmaceuticals. We developed a lipofection enhancer based on histone deacetylase inhibitor. Gene expression can be increased to up to 10 times more than that of the conventional method by adding the enhancer to commercially available lipofection reagents. |
[Technology Classification]
-BA01/Life Innovation/Drug Discovery & Diagnosis/Drugs (Low Molecule)
-BA03/Life Innovation/Drug Discovery & Diagnosis/Drugs (Nucleic Acid)
[Product Classification]
-A002/Basic Technology/Basic & Fundamental Technology/Reagents
|
+81-6-6368-1121
|
| University |
Kobe Gakuin University
|
Laboratory of Food and Nutritional Science
Yoshiyuki Mizushina
|
(1) Screening of selective inhibitors of eukaryotic (mammalian) DNA polymerase (pol) species, and development of anti-cancer and anti-inflammatory effectiveness.1) Screening of novel compounds from marine microorganisms which are parasitic on wild sea alga, coral and moss.2) Pol inhibitors from waste materials of foods, and development of healthy functional foods.(2) Development of screening methods of anti-inflammatory compounds, and anti-inflammatory drugs such as curcumin derivatives, vitamin K derivatives and sulfobacin B. |
[Technology Classification]
-BA01/Life Innovation/Drug Discovery & Diagnosis/Drugs (Low Molecule)
[Product Classification]
-BA02/Life Innovation/Drug Discovery & Diagnosis/Therapeutic Agent
-A002/Basic Technology/Basic & Fundamental Technology/Reagents
|
+81-78-974-1551
|
| University |
Kwansei Gakuin University
|
School of Science and Technology, Department of Chemistry
Hidetoshi Yamada
|
We have conducted research related to synthesis of naturally occurring organic compounds and are studying about organic chemical aspects of sugars. Chemical synthesis of natural products involves preparing organic products with complex chemical-structures via various steps of chemical reactions from simple organic compounds. We have pursued artificially-synthesizing methods of pharmaceutically active compounds which naturally occur in trace amounts and novel functional compounds. We have also developed novel reactions in order to synthesize objective compounds efficiently.With regard to the studies about sugars, we have recently succeeded in altering to a great extent, the characteristic structures which various sugars have in nature. Chain sugars consisting of many sugars play important roles in an organism. For example, they decide ABO blood type. However, even if we attempt to study the functions of natural chain sugars, they can be obtained only in trace amounts because there are a wide variety of sugars due to the fact that functions vary from sugar to sugar, their purification is difficult, and they are found in only trace amounts in the natural world. Accordingly we have conducted research with the objective of developing an efficient synthesis method of sugar chains using structure-altered sugars. |
[Technology Classification]
-BA05/Life Innovation/Drug Discovery & Diagnosis/Drugs (Carbohydrate)
[Product Classification]
-A002/Basic Technology/Basic & Fundamental Technology/Reagents
-BA02/Life Innovation/Drug Discovery & Diagnosis/Therapeutic Agent
|
+81-79-565-9052
ip.renkei@kwansei.ac.jp |
| University |
Kwansei Gakuin University
|
School of Science and Technology, Department of Chemistry
Shigeo Katsumura
|
There are many kinds of organic compounds in nature. They are utilized in various fields. Among these organic compounds, we have synthesized physiologically-active compounds and their related chemicals. For example, we have studied the synthesis of antibacterial compounds, enzyme-activity suppressing compounds, and highly oxidized carotenoids.Simple and highly selective methods are necessary in order to synthesize molecules such as terpenoids, phospholipids and alkaloids etc.Accordingly we have been studying novel and efficient synthetic methods using light, heat, oxygen, and organic metals etc. In this way, we have targeted on elucidating how the phenomenan called physiological-activity occurs at the chemical reaction level as well as developing and providing novel organic tool-molecules suitable for understanding of biological phenomena. |
[Technology Classification]
-BA01/Life Innovation/Drug Discovery & Diagnosis/Drugs (Low Molecule)
[Product Classification]
-A002/Basic Technology/Basic & Fundamental Technology/Reagents
-BA02/Life Innovation/Drug Discovery & Diagnosis/Therapeutic Agent
|
+81-79-565-9052
ip.renkei@kwansei.ac.jp |
| University |
Kwansei Gakuin University
|
School of Science and Technology, Department of Bioscience
Kiyoji Nishiwaki
|
The developing process in an animal from ovum to parent is called genesis. Fertile ovum consisting of one single cell grows by repeated cell division to become a human body consisting of about 60 trillions of cells. During the process of genesis, cells frequently move from the origin site to the predetermined site, where they grow into tissues or organs. For example, germ cells enter the testis or ovary, and the endothelial cells of the veins extend the veins by proliferation and migration. We have conducted research on the mechanisms of cell migration with use of nematode as an experimental material. The nematode is 1mm in length and is shaped like an earthworm. Even an adult nematode has only 959 cells and all the cell migrations in the process of genesis are known. Furthermore, about 70% of the nematode genes are similar to human genes. Most of the cell migration-controlling genes confirmed in the researches of nematodes also exist in humans and the cell migration mechanisms which have been evolutionarily conserved are becoming to reveal. |
[Product Classification]
-A002/Basic Technology/Basic & Fundamental Technology/Reagents
|
+81-79-565-9052
ip.renkei@kwansei.ac.jp |
| University |
Osaka Prefecture University, School of Life and Environmental Sciences
|
Laboratory of Cellular and Molecular Biology, Veterinary Science
Masayuki Komori
|
We utilize mass spectrometry and molecular biological techniques as a means to reveal the significance of protein modifications in biological function within cellular organelle. |
[Technology Classification]
-A002/Basic Technology/Basic & Fundamental Technology/Protein Synthesis
-A004/Basic Technology/Basic & Fundamental Technology/Analysis of Protein Structure
-A013/Basic Technology/Basic & Fundamental Technology/Organera
[Product Classification]
-A001/Basic Technology/Basic & Fundamental Technology/Equipments
-A002/Basic Technology/Basic & Fundamental Technology/Reagents
|
+81-72-463-5297
katsuhiro_t@msn.com |
| Others |
Biostir Inc.
|
Shigeki Takaki
|
Biostir AD, a challenging ointment for atopic dermatitis, contains a large amount of allergens from Dermatophagoides farinae and can develop symptoms similar to human atopic dermatitis on the dorsal skin of NC/Nga mice at a high incidence rate with stability.You can observe frequent scratching behavior of mice. This model can be useful for the study of itching and development of related products. |
[Product Classification]
-A002/Basic Technology/Basic & Fundamental Technology/Reagents
|
+81-78-894-3113
info@biostir.com |
